While the increase in price target from $95 to $105 by JP Morgan suggests a positive outlook on Qorvo's valuation, the Underweight rating indicates ongoing concerns about the company's performance relative to the market. This mixed signal could lead to neutral short-term price movement as investors weigh the increased target against the cautious rating.